✦ LIBER ✦

Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite

✍ Scribed by Susan Grinnell; Koji Yoshida; Hugo E. Jasin

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 66 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.20760

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the response to infliximab

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

✍ Kimme L. Hyrich; Deborah P. M. Symmons; Kath D. Watson; Alan J. Silman; British 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Abstract ## Objective To compare outcome at 6 months in unselected “real‐world” patients with rheumatoid arthritis treated with etanercept or infliximab as either monotherapy, cotherapy with methotrexate (MTX), or cotherapy with another disease‐modifying antirheumatic drug (DMARD). ## Methods

Phase IIb dose-ranging study of the oral

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

✍ Roy Fleischmann; Maurizio Cutolo; Mark C. Genovese; Eun Bong Lee; Keith S. Kanik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 3 views

An alternative, autonomic rationale for

An alternative, autonomic rationale for decreased risk of myocardial infarction in patients with rheumatoid arthritis responsive to anti–tumor necrosis factor therapy: Comment on the article by Dixon et al

✍ Andrew J. Holman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

Ofatumumab, a human anti-CD20 monoclonal

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

✍ Mikkel Østergaard; Bo Baslund; William Rigby; Bernadette Rojkovich; Christian Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

Effect of the 34C>T variant in the AMPD1

Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: Comment on the article by Wessels et al

✍ Niels P. Riksen; Gerard A. Rongen; Paul Smits; Piet van Riel; Pilar Barrera 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views